MedTrace Logo

The Influence Of a Natural Anti-Inflammatory Product On Levels Of Inflammatory Markers In Cases With Osteoarthritis Of Knee

NCT02333084 · Status: UNKNOWN · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2016-08-04

No results posted yet for this study

Summary

This is a randomized, placebo controlled study. The first subject is expected to be enrolled in July 2014, and the last subject is expected to complete the study by July 2015. Each subject will be provided with the PRN Joint Comfort Formula, placebo or PRN Flex Omega Benefits® combination depending on randomization (1:1:1 at each site) during the course of the study. Instructions and frequency of use will be determined by the labelling.

Conditions

Interventions

DIETARY_SUPPLEMENT

PRN Joint Health Formula

DIETARY_SUPPLEMENT

placebo

DIETARY_SUPPLEMENT

PRN Flex Omega Benefits® combination

Sponsors & Collaborators

  • Rothman Institute Orthopedics

    collaborator UNKNOWN

  • Physician Recommended Nutriceuticals

    lead INDUSTRY

Principal Investigators

  • Javad Parvizi, MD · Rothman Institute

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-07-31
Primary Completion
2017-07-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02333084 on ClinicalTrials.gov